Dr. Mubarak Al Mansour

MB;ChB, ABIM, FRCPC , MMedEd

  • Education

    • 2012-2014: Masters in Medical Education, College of Medicine – Jeddah, King Saud bin Abdulaziz for Health Sciences (KSA)
    • 2008-2009: Lymphoma Fellowship, British Columbia Cancer Agency, Vancouver (Canada)
    • 2006-2008: Medical Oncology Fellowship, British Columbia Cancer Agency, Vancouver (Canada)
    • 2003-2006: Internal Medicine Residency, University of the British Columbia (Canada)
    • 2000-2001: Internship, King Abdulaziz University Hospital (KSA)
    • 1998-1999: Bachelor of Medicine & Surgery, King Abdulaziz University (KSA)
  • Professional Experience

    ACADEMIC POSITION

    • 2013- 03 Nov. 2018: Assistant Professor, Internal Medicine / Oncology, College of Medicine – Jeddah, KSAU-HS (KSA)
    • 04 November 2018 – Present: Associate Professor, Internal Medicine / Oncology, College of Medicine – Jeddah, KSAU-HS (KSA)

    ADMINISTRATIVE POSITION

    • 2017-Present: Associate Dean, Academic & Student Affairs, College of Medicine – Jeddah, KSAU-HS (KSA)
    • 2016-Present: Section Head, Adult Medical Oncology, Princess Norah Oncology Center – WR, MNGHA (KSA)
    • 2014-Present: Chairman, Department of Medical Education, College of Medicine – Jeddah, KSAU-HS (KSA)

    CLINICAL POSITION

    • 2009-Present: Consultant, Adult Medical Oncology, Princess Norah Oncology Center – WR, MNGHA (KSA)
  • Publications

    1. Ezzeldin M. Ibrahim, Wesal M. Eldahna, Omalkhair A. Abulkhair, Mubarak M. Al-Mansour. CDK 4/6 Inhibitors in Hormone Receptor-Positive Advanced Breast Cancer: A Meta-analysis. Trends Cancer Res Chemother 1: doi: 10.15761/TCRC.1000113, OAT, ISSN: 2517-7206, Volume 1(3): 8-8, September 24, 2018
    1. Abdullah Alsharm, Shouki Bazarbashi, Abdullah Alghamdi, Sultan Alkhateeb, Ali Aljubran, Ashraf Abusamra, Hulayel Alharbi, Mohammed Alotaibi, Mubarak Almansour, Hussein Alkushi, Imran Ahmed9, Esam Murshid, Amin Eltijani, Danny Rabah. Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for renal cell carcinoma 2017. Urology Annals, ISSN: 0974-7796, Volume 10 |Issue 2 | April-June 2018, 123-132
    1. Hulayel Alharbi, Sultan Alkhateeb, Esam Murshid, Mohammed Alotaibi, Ashraf Abusamra, Danny Rabah, Mubarak Almansour, Abdullah Alghamdi, Ali Aljubran, Amin Eltigani, Hussein Alkushi, Imran Ahmed, Abdullah Alsharm, Shouki Bazarbashi. Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder 2017. Urology Annals, ISSN: 0974-7796, Volume 10 |Issue 2 | April-June 2018, 133-137
    1. Ali Aljubran, Ashraf Abusamra, Sultan Alkhateeb, Mohammed Alotaibi, Danny Rabah, Shouki Bazarbashi, Hussain Alkushi, Mubarak AlMansour, Hulayel Alharbi, Amin Eltijani, Abdullah Alghamdi, Abdullah Alsharm, Imran Ahmad, Esam Murshid. Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for prostate cancer 2017. Urology Annals, ISSN: 0974-7796, Volume 10 |Issue 2 | April-June 2018, 138-145
    1. Al-Mansour MM, Alghamdi SA, Alsubaie MA, Alesa AA, Khan MA. Negative Effect of Hepatitis in Overall and Progression-Free Survival among Patients with Diffuse Large B-Cell Lymphoma with Manuscript No. IAAC-D-18-00020. Accepted for Publication on 30 May 2018 and final proof done.
    1. Shafi R.G.a· Al-Mansour M.M.a· Kanfar S.S.b· Al Hashmi H.b· Alsaeed A.a· Al-Foheidi M.a· Ibrahim E.M.c, Hodgkin Lymphoma Outcome: A Retrospective Study from 3 Tertiary Centers in Saudi Arabia, Oncol Res Treat 2017;40:- (DOI: 10.1159/000460819)  (Karger Journals).
    1. Zekri J, Imtiaz S, Al Mansour M, Darwish W. Sunitinib tolerance and efficacy in patients with metastatic renal cell carcinoma according to ethnic and geographic factors. Int Urol Nephrol. 2017 Jan 9. DOI: 10.1007/s11255-017-1502-5. 28070728 [PubMed].
    1. Ahmad A Algarni, Sulaiman Anagreyyah, Mubarak Al-Mansour, Salwa Alaidarous. Perception of family medicine residents towards use of portfolio in their assessment in joint program of family medicine, Jeddah, Saudi Arabia, 2015, International Journal of Medical Science and Public Health | 2017 | Vol 6 | Issue 1
    1. EM Ibrahim, GA Kazkaz, MM Al-Mansour, ME Al-Foheidi. The predictive and prognostic role of phosphatase phosphoinositol-3 (PI3) kinase (PIK3CA) mutation in HER2-positive breast cancer receiving HER2-targeted therapy: a meta-analysis. Breast cancer research and treatment 152 (3), 463-476, 2015
    1. WA Al-Jizani, MM Al-Mansour, TM Al-Fayea, RU Shafi, GA Kazkaz. Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin’s lymphoma. Future Oncology 11 (15), 2149-2157, 2015
    1. Bazarbashi S, Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, Almansour M, et al. Saudi oncology society and Saudi urology association combined clinical management guidelines for renal cell carcinoma. Urology annals. 2014 Oct;6(4):286-9. PubMed PMID: 25371602. Pubmed Central PMCID: 4216531.
    1. Alotaibi M, Bazarbashi S, Alkhateeb S, Abusamra A, Rabah D, Almansour M, et al. Saudi oncology society and Saudi urology association combined clinical management guidelines for testicular germ cell tumors. Urology annals. 2014 Oct;6(4):290-5. PubMed PMID: 25371603. Pubmed Central PMCID: 4216532.
    1. Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, Mahmood R, Almansour M, et al. Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer. Urology annals. 2014 Oct;6(4):278-85. PubMed PMID: 25371601. Pubmed Central PMCID: 4216530.
    1. Al-Mansour M, Saadeddin A, Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, et al. Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer. Urology annals. 2014 Oct;6(4):273-7. PubMed PMID: 25371600. Pubmed Central PMCID: 4216529.
    1. Xing KH, Connors JM, Lai A, Al-Mansour M, Sehn LH, Villa D, et al. Advanced Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma Compared to Classical Hodgkin Lymphoma: A Matched Pair Outcome Analysis. Blood. 2014 Apr 8. PubMed PMID: 24713929.
    1. MM Al-Mansour, WA Al-Jizani, T Al-Fayea, S Ruaa, GA Kazkaz, AM Bayer. Bleomycin Pulmonary Toxicity in Adult Saudi Patients with Hodgkin’s Lymphoma. Blood 124 (21), 5450-5450, 2014
    1. EM Ibrahim, M Al-Foheidi, MM Al-Mansour, GA Kazkaz, TE Yunus. The prognostic and predicting roles of tumor-Infiltrating lymphocytes in breast cancer: a meta-analysis. The Open Breast Cancer Journal 6 (1), 1, 2014
    1. EM Ibrahim, ME Al-Foheidi, MM Al-Mansour, GA Kazkaz. The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis. Breast cancer research and treatment 148 (3), 467-476, 13, 2014
    1. Al-Foheidi M, Al-Mansour MM, Ibrahim EM. Breast Cancer Screening: Review of Benefits and Harms, and Recommendations for Developing and Low-Income Countries. Medical oncology. 2013 Jun;30(2):471. PubMed PMID: 23420062.
    1. EM Ibrahim, M. Al-Foheidi, Al Mansour, GA Kazkaz. Clinical Utility of Cetuximab-Induced Skin Toxicity: The Jury is still out. Journal of Symptoms and Signs 2 (5), 315. 2013
    1. Al-Mansour MM, Al-Foheidi M, Ghieth A Kazkaz, Ibrahim EM. Interim FDG-PET in Diffuse Large B-Cell Non- Hodgkin’s Lymphoma: A Meta-Analysis. World J Med Res. 2013 2013(2):25-45.
    1. Ibrahim EM, Kazkaz GA, Abouelkhair KM, Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, et al. Increased Risk of Second Lung Cancer in Hodgkin’s Lymphoma Survivors: A Meta-analysis. Lung. 2013 Feb;191(1):117-34. PubMed PMID: 23053567.
    1. KH Xing, JM Connors, Al Mansour, RD Gascoyne, B. Skinnider. The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin’s Lymphoma (NLPHL) Compared to Classical Hodgkin’s lymphoma (CHL): A Matched Pair Analysis. Blood 120 (21), 2012
    1. Savage KJ, Skinnider B, Al-Mansour M, Sehn LH, Gascoyne RD, Connors JM. Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome. Blood. 2011 Oct 27;118(17):4585-90. PubMed PMID: 21873543
    1. KJ Savage, B Skinnider, Al Mansour, LH Sehn, RD Gascoyne. Incorporation of ABVD Increases Cure Rates of Patients with Limited Stage Nodular lymphocyte Predominant Hodgkin Lymphoma (NLPHL). Blood 116 (21), 1587, 2010
    1. Al-Mansour M, Connors JM, Gascoyne RD, Skinnider B, Savage KJ. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin’s lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Feb 10;28(5):793-9. PubMed PMID: 20048177.